Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease

NCT00549146 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: fluticasone propionate/salmeterol 250/50 DISKUS combination product
DRUG: fluticasone propionate DISKUS 500mcg

Sponsor

GlaxoSmithKline